Dronedarone Reduces CV Hospitalization, Death in Patients With AF With, Without T2D - The Cardiology Advisor

Researchers sought to assess the safety and efficacy of dronedarone therapy for patients with atrial fibrillation and diabetes.

In patients with atrial fibrillation (AF) and atrial flutter (AFL) both with and without diabetes, treatment with the multichannel blocking antiarrhythmic agent dronedarone has demonstrated efficacy … [+4443 chars]

full article...